Newest Hospital in New England Signs Agreement With Global Med Technologies(R), Inc.
March 06 2008 - 9:00AM
PR Newswire (US)
Unique Facility is First New Maine Hospital in 25 Years DENVER,
March 6 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
(OTC:GLOB) (BULLETIN BOARD: GLOB) , an international e-Health,
medical information technology company, announced today that its
Wyndgate Technologies(R) division has signed an agreement with Mid
Coast Hospital (Mid Coast) of Brunswick, Maine, to license its
SafeTrace Tx(R) transfusion management software. Terms of the
agreement were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Sue
Ross, Director of Laboratory Services for Mid Coast Hospital, cited
the extensive safety features throughout the system as the primary
reasons for choosing SafeTrace Tx. "After a thorough search for
transfusion software, we were impressed with Wyndgate software's
ability to grow with our expanding department and interface with
our existing Laboratory Information System." Ms. Ross continued,
"Our hospital's recent unprecedented growth requires a
user-friendly transfusion system that can grow with us. SafeTrace
Tx is a Windows(R)-based system which will help create efficiencies
in the lab. It will also help us to increase safety by accurately
tracking patient and product compatibility." SafeTrace Tx is
uniquely designed to support the full scale of transfusion services
from enterprise-wide centralized facilities to small, individual
hospital laboratories. Advanced functionality in SafeTrace Tx, such
as electronic crossmatch, automated patient special needs tracking
and antigen/antibody functionality, will assist Mid Coast in
matching patients for transfusions. SafeTrace Tx is intended to
help raise the standard of care for patients, improve safety,
reduce waste and increase efficiency for blood transfusion
services. Wm. Scott Dustin, Vice President of Sales and Marketing
for Wyndgate Technologies, commented, "We are delighted that Mid
Coast Hospital has chosen Wyndgate to manage the transfusion
service in their new state-of-the-art facility. As a leading
developer of blood management systems, Wyndgate's commitment to its
customers is to continue to provide advanced blood management
systems which are functionally rich, reliable, and help to enhance
patient care and safety by providing dependable access to critical
information." About Mid Coast Hospital Mid Coast Hospital, which
opened on December 11, 2001, is the newest full-service community
hospital in New England. A state-of-the-art hospital and medical
center facility, it offers acute care, inpatient, and outpatient
medical facilities to 22 neighboring communities. In the past year,
Mid Coast has experienced tremendous growth in its clinical
departments, which has resulted in significantly increased volume
in its blood bank. About Global Med Technologies, Inc. Global Med
Technologies(R), Inc. is an international e-Health medical
information technology company providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies(R) division is a leading supplier of
information management systems to U.S. and international blood
centers and hospital transfusion centers. Each year, Wyndgate's
products and services manage more than eight million blood
components, representing over 27% of the U.S. blood supply.
Wyndgate's products are also being used in Canada, Africa, and the
Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking
from donor collection to patient transfusion through its Donor
Doc(TM) interactive donor health history questionnaire, ElDorado
Donor(TM) and SafeTrace(R) donor management systems, to its
SafeTrace Tx(R) advanced transfusion management system. Global
Med's PeopleMed(R), Inc. subsidiary provides custom software
validation, consulting and compliance solutions to hospitals and
blood centers. PeopleMed's in-depth knowledge of Wyndgate's
products and the blood banking industry results in cost-effective
validation services, which leads to more efficient software
implementations and upgrades for our customers. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or Investors, Paul Holm, President of
portfoliopr.inc, +1-212-999-5585, , for Global Med Technologies,
Inc. Web site: http://www.globalmedtech.com/
http://www.peoplemed.com/ http://www.wyndgate.com/
Copyright